Y. Lee

发表

Older age should not be a barrier to testing for somatic variants in homologous recombination DNA repair-related genes in patients with high-grade serous ovarian carcinoma

A. deFazio, P. Beale, R. Balleine, 2023, Translational oncology.

Symptom burden and quality of life with chemotherapy for recurrent ovarian cancer: the Gynecologic Cancer InterGroup-Symptom Benefit Study

M. Stockler, A. Oza, A. Okamoto, 2022, International Journal of Gynecological Cancer.

Insights into ovarian cancer care: report from the ANZGOG Ovarian Cancer Webinar Series 2020

P. Beale, C. Scott, G. Kichenadasse, 2021, Journal of gynecologic oncology.

Measure of Ovarian Symptoms and Treatment concerns (MOST) indexes and their associations with health-related quality of life in recurrent ovarian cancer.

M. Stockler, A. Oza, A. Okamoto, 2022, Gynecologic oncology.

Clinical activity of durvalumab for patients with advanced mismatch repair-deficient and repair-proficient endometrial cancer. A nonrandomized phase 2 clinical trial

M. Stockler, A. Spurdle, P. Beale, 2021, Journal for ImmunoTherapy of Cancer.

Adjuvant chemotherapy following chemoradiation as primary treatment for locally advanced cervical cancer compared to chemoradiation alone: The randomized phase III OUTBACK Trial (ANZGOG 0902, RTOG 1174, NRG 0274).

B. Monk, M. Stockler, V. Gebski, 2021 .

Tumor-associated immune cells and progression-free survival in advanced endometrial cancer (EC), results from the PHAEDRA trial (ANZGOG 1601).

M. Stockler, A. Spurdle, P. Beale, 2021 .

TRACEBACK: Testing of Historical Tubo-Ovarian Cancer Patients for Hereditary Risk Genes as a Cancer Prevention Strategy in Family Members

Dale W. Garsed, Kenneth D. Doig, L. Andrews, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment patterns after poly-ADP ribose polymerase (PARP) inhibitors in epithelial ovarian cancer patients

K. Webber, L. Mileshkin, M. Friedlander, 2022, International Journal of Gynecological Cancer.

Patient-Reported Outcomes in Ovarian Cancer: Facilitating and Enhancing the Reporting of Symptoms, Adverse Events, and Subjective Benefit of Treatment in Clinical Trials and Clinical Practice

M. Stockler, M. Friedlander, F. Roncolato, 2023, Patient related outcome measures.

Results of PD-L1 Analysis of Women Treated with Durvalumab in Advanced Endometrial Carcinoma (PHAEDRA)

M. Stockler, A. Spurdle, P. Beale, 2022, Cancers.

Adjuvant chemotherapy following chemoradiotherapy as primary treatment for locally advanced cervical cancer versus chemoradiotherapy alone (OUTBACK): an international, open-label, randomised, phase 3 trial.

B. Monk, M. Stockler, V. Gebski, 2023, The Lancet. Oncology.

IGNITE: A phase II signal-seeking trial of adavosertib targeting recurrent high-grade, serous ovarian cancer with cyclin E1 overexpression with and without gene amplification.

L. Mileshkin, G. Kichenadasse, M. Bressel, 2022, Journal of Clinical Oncology.

Exercise during CHemotherapy for Ovarian cancer (ECHO) trial: design and implementation of a randomised controlled trial

M. Stockler, L. Mileshkin, M. Friedlander, 2023, BMJ Open.

Managing Adverse Effects Associated With Poly (ADP-ribose) Polymerase Inhibitors in Ovarian Cancer: A Synthesis of Clinical Trial and Real-World Data.

M. Friedlander, W. Tew, Y. Lee, 2023, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

Clinical Trial Protocol for HyNOVA: Hyperthermic and Normothermic intraperitoneal chemotherapy following interval cytoreductive surgery for stage III epithelial OVArian, fallopian tube and primary peritoneal cancer (ANZGOG1901/2020).

M. Stockler, K. Robledo, R. Mercieca-Bebber, 2021, Journal of gynecologic oncology.

Cell-free DNA is abundant in ascites and represents a liquid biopsy of ovarian cancer.

A. deFazio, V. Arora, C. Ford, 2021, Gynecologic oncology.

Mucinous ovarian carcinoma: A survey of practice in Australia and New Zealand.

P. Allan, P. Khaw, Hugo Saunders, 2024, The Australian & New Zealand journal of obstetrics & gynaecology.